Criteria suggested by ESC 2019 [19] and ADA 2020 [21] for considering the screening of CAD in type 2 asymptomatic diabetic patients
| ESC 2019: patients at very high risk, i.e. with any of the following: | ADA 2020: presence of any of the following: |
|---|---|
- Peripheral arterial disease - High CAC score (> 400 Agatston) - Proteinuria - Renal failure [eGFR < 30 mL/(min·1.73 m2) ] - Left ventricular hypertrophy - Retinopathy - Three of more major risk factors (age, hypertension, dyslipidemia, smoking, obesity) | - Atypical cardiac symptoms (unexplained dyspnea, chest discomnfort) - Signs or symptoms of associated vascular disease [including carotid bruits, transient ischemic attacks, stroke, claudication, peripheral artery disease, electrocardiogram abnormalities (e.g. Q waves) ] |
eGFR: estimated glomerular filtration rate
